HC Wainwright Has Negative Forecast for SCPH FY2024 Earnings
scPharmaceuticals Inc. (NASDAQ:SCPH – Free Report) – Equities researchers at HC Wainwright reduced their FY2024 earnings estimates for scPharmaceuticals in a research report issued on Monday, March 3rd. HC Wainwright analyst D. Tsao now expects that the company will post earnings of ($1.44) per share for the year, down from their prior estimate of ($1.43). […]
